Stimuli-responsive In situ gelling system for nose-to-brain drug delivery

M Agrawal, S Saraf, S Saraf, SK Dubey, A Puri… - Journal of Controlled …, 2020 - Elsevier
The diagnosis and treatment of neurological ailments always remain an utmost challenge for
research fraternity due to the presence of BBB. The intranasal route appeared as an …

Progress in nasal drug delivery systems

F Laffleur, B Bauer - International Journal of Pharmaceutics, 2021 - Elsevier
Most of the available drugs are usually administered orally (eg in tablets or capsules) or by
parenteral injection in the case of substances being destroyed in the gastric environment or …

Polymeric in situ forming depots for long-acting drug delivery systems

AK Pandya, LK Vora, C Umeyor, D Surve… - Advanced Drug Delivery …, 2023 - Elsevier
Polymeric in situ forming depots have emerged as highly promising drug delivery systems
for long-acting applications. Their effectiveness is attributed to essential characteristics such …

Glaucoma: current treatment and impact of advanced drug delivery systems

KS Yadav, R Rajpurohit, S Sharma - Life sciences, 2019 - Elsevier
The human eye being a complex and a very sensitive organ makes the drug delivery task
challenging. An increase in the intra-ocular pressure at the aqueous humour leads to …

Targeted drug delivery to the brain via intranasal nanoemulsion: Available proof of concept and existing challenges

B Chatterjee, B Gorain, K Mohananaidu… - International journal of …, 2019 - Elsevier
Intranasal delivery has shown to circumvent blood-brain-barrier (BBB) and deliver the drugs
into the CNS at a higher rate and extent than other conventional routes. The mechanism of …

The use of TPGS in drug delivery systems to overcome biological barriers

MT Luiz, LD Di Filippo, RC Alves, VHS Araújo… - European Polymer …, 2021 - Elsevier
Nanotechnology has been applied in the medicine field to improve the treatment of a wide
range of diseases. However, to reach the nanomedicines delivery to desirable target tissue …

Nasal drug delivery of anticancer drugs for the treatment of glioblastoma: preclinical and clinical trials

FA Bruinsmann, G Richter Vaz… - Molecules, 2019 - mdpi.com
Glioblastoma (GBM) is the most lethal form of brain tumor, being characterized by the rapid
growth and invasion of the surrounding tissue. The current standard treatment for …

Lipid nanoparticles for nasal/intranasal drug delivery

S Cunha, MH Amaral, JMS Lobo… - Critical Reviews™ in …, 2017 - dl.begellhouse.com
Studies on the development of drug delivery systems have increased because these
systems have particular characteristics that allow them to improve therapeutics. Among …

Recent advances in intranasal administration for brain-targeting delivery: a comprehensive review of lipid-based nanoparticles and stimuli-responsive gel formulations

J Koo, C Lim, KT Oh - International Journal of Nanomedicine, 2024 - Taylor & Francis
Addressing disorders related to the central nervous system (CNS) remains a complex
challenge because of the presence of the blood-brain barrier (BBB), which restricts the entry …

[HTML][HTML] Nanotechnological advances for nose to brain delivery of therapeutics to improve the Parkinson therapy

DK Khatri, K Preeti, S Tonape… - Current …, 2023 - ncbi.nlm.nih.gov
Abstract Blood-Brain Barrier (BBB) acts as a highly impermeable barrier, presenting an
impediment to the crossing of most classical drugs targeted for neurodegenerative diseases …